Tirzepatide – 30mg

1. Type 2 Diabetes and Metabolic Regulation
   Tirzepatide acts by binding to both GIP and GLP-1 receptors, stimulating pancreatic insulin release and promoting better blood glucose control. This dual mechanism offers a broader metabolic effect than GLP-1 analogues alone, making Tirzepatide a focus of research for diabetes and related metabolic disorders.
   
2. Cardiovascular Protection
   Research suggests Tirzepatide may improve cardiovascular outcomes by reducing blood glucose and body weight, as well as increasing adiponectin levels by up to 26%, a protein linked with improved insulin sensitivity and anti-inflammatory effects.
   
3. Appetite and Satiety Control
   By activating both incretin receptors, Tirzepatide enhances satiety and reduces appetite, supporting research into obesity and weight management therapies.
   
4. Non-Alcoholic Fatty Liver Disease (NAFLD)
   Tirzepatide’s effects on insulin sensitivity and adiponectin also make it a candidate for studies into NAFLD and related liver conditions.

Store lyophilized Tirzepatide at -20°C in a sealed, light-protected container. Reconstituted peptide should be used within recommended timeframes and stored at 2–8°C. Protect from moisture and direct light. Reconstitute with bacteriostatic water or other lab-approved diluents as per experimental protocol.

Tirzepatide is intended solely for scientific research and preclinical studies. It is not approved for human or veterinary use and should be handled only by qualified personnel in controlled laboratory settings. All True Science Peptides products undergo third-party purity verification via HPLC and mass spectrometry and include batch-specific Certificates of Analysis.